RecruitingPhase 4NCT04140578
Antibiotic Prophylaxis in Patients Undergoing GVO
Antibiotic Prophylaxis in Patients Undergoing Endoscopic Injection of Cyanoacrylate for Primary and Secondary Prevention of Gastric Variceal Bleeding
Sponsor
Taipei Veterans General Hospital, Taiwan
Enrollment
150 participants
Start Date
Jan 28, 2017
Study Type
INTERVENTIONAL
Conditions
Summary
We design a randomized trial to clarify the necessity of antibiotic prophylaxis for the patients chronic liver disease with gastric varices treated by elective GVO.
Eligibility
Min Age: 20 YearsMax Age: 85 Years
Inclusion Criteria2
- Patients with live cirrhosis and/or hepatoma
- Aged 20 to 85, who had endoscopy-treatment EV(-)GV(+)or EV\<GV
Exclusion Criteria3
- Had a terminal illness of any major organ system,such as heart failure, kindey failure,COPD
- Patients recieve antibiotics recently.
- Patients suspected infection.
Interventions
DRUGErtapenem
inject from iv drip before endoscopic cyanoacrylateinjection obliteration
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04140578
Related Trials
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT0568144228 locations
Safe and Explainable AI
NCT066941811 location
Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts
NCT074328931 location
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
NCT070581551 location
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
NCT072911411 location